Wird geladen...
High metallothionein predicts poor survival in glioblastoma multiforme
BACKGROUND: Glioblastoma multiforme (GBM) is the most common and aggressive malignant brain tumor. Even with vigorous surgery, radiation and chemotherapy treatment, survival rates of GBM are very poor and predictive markers for prognosis are currently lacking. METHODS: We performed whole genome expr...
Gespeichert in:
| Veröffentlicht in: | BMC Med Genomics |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4618994/ https://ncbi.nlm.nih.gov/pubmed/26493598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12920-015-0137-6 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|